Search research articles
Contact Us
Filters
Showing results (411-420 of 493) with videos related to
Page
of 50
Sort By:
CA: a Cancer Journal for Clinicians
|
June 16, 2004
An evidence-based staging system for cutaneous melanoma
Charles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2020
Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab <b>+</b> Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma
Michael B Atkins, Brian I Rini, Robert J Motzer, et al.
Cancer Cell
|
November 6, 2020
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J Motzer, Romain Banchereau, Habib Hamidi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2017
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Mario Sznol, Pier Francesco Ferrucci, David Hogg, et al.
European Urology
|
July 17, 2022
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma
Jens Bedke, Brian I Rini, Elizabeth R Plimack, et al.
Seminars in Surgical Oncology
|
August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomes
Charles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Gastroenterology
|
December 11, 2020
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice
Ivana Peran, Sivanesan Dakshanamurthy, Matthew D McCoy, et al.
Cancer
|
March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanoma
C M Balch, A C Buzaid, M B Atkins, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204
Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.
Page
of 50
Search research articles
Search
Showing results (411-420 of 493) with videos related to
Sort By:
Page
of 50
CA: a Cancer Journal for Clinicians
|
June 16, 2004
An evidence-based staging system for cutaneous melanoma
Charles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2020
Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab <b>+</b> Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma
Michael B Atkins, Brian I Rini, Robert J Motzer, et al.
Cancer Cell
|
November 6, 2020
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J Motzer, Romain Banchereau, Habib Hamidi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2017
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Mario Sznol, Pier Francesco Ferrucci, David Hogg, et al.
European Urology
|
July 17, 2022
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma
Jens Bedke, Brian I Rini, Elizabeth R Plimack, et al.
Seminars in Surgical Oncology
|
August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomes
Charles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Gastroenterology
|
December 11, 2020
Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice
Ivana Peran, Sivanesan Dakshanamurthy, Matthew D McCoy, et al.
Cancer
|
March 16, 2000
A new American Joint Committee on Cancer staging system for cutaneous melanoma
C M Balch, A C Buzaid, M B Atkins, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204
Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.
Page
of 50